Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Reimbursement Briefs: Medicare Payments For New Drugs; 340B Rules; HHS' Best

Nov 02 2018

• By Cathy Kelly

HHS Building_1200

Related Content

The Best Choice: HHS Lead On Drug Price Reform Brings Expertise In Part D Contracting

Mar 30 2018

340B Drug Pricing, Penalties Need To Be Implemented, Congressional Leaders Say

Aug 29 2018

Medicare Payments For Sensipar, Parsabiv Could Be Bellwether For Dialysis Drug Developers

Sep 27 2018

Breaking 340B: What Happens After Medicare Payment Cut?

Jan 12 2018

Medicare Reimbursement For New Part B Drugs Lowered In Proposal

Jul 17 2018

Related Companies

Amgen, Inc.

Additional Topics

US States Regulation Pricing Debate BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window